These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 17867931)

  • 1. Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease?
    Leuner K; Hauptmann S; Abdel-Kader R; Scherping I; Keil U; Strosznajder JB; Eckert A; Müller WE
    Antioxid Redox Signal; 2007 Oct; 9(10):1659-75. PubMed ID: 17867931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease--therapeutic aspects.
    Müller WE; Eckert A; Kurz C; Eckert GP; Leuner K
    Mol Neurobiol; 2010 Jun; 41(2-3):159-71. PubMed ID: 20461558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease.
    Hauptmann S; Keil U; Scherping I; Bonert A; Eckert A; Müller WE
    Exp Gerontol; 2006 Jul; 41(7):668-73. PubMed ID: 16677790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons.
    Reddy PH
    Antioxid Redox Signal; 2007 Oct; 9(10):1647-58. PubMed ID: 17696767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice.
    Hauptmann S; Scherping I; Dröse S; Brandt U; Schulz KL; Jendrach M; Leuner K; Eckert A; Müller WE
    Neurobiol Aging; 2009 Oct; 30(10):1574-86. PubMed ID: 18295378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease.
    Grimm A; Friedland K; Eckert A
    Biogerontology; 2016 Apr; 17(2):281-96. PubMed ID: 26468143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into mitochondrial dysfunction: aging, amyloid-β, and tau-A deleterious trio.
    Schmitt K; Grimm A; Kazmierczak A; Strosznajder JB; Götz J; Eckert A
    Antioxid Redox Signal; 2012 Jun; 16(12):1456-66. PubMed ID: 22117646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal transport and mitochondrial dysfunction in Alzheimer's disease.
    Riemer J; Kins S
    Neurodegener Dis; 2013; 12(3):111-24. PubMed ID: 23037012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
    Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
    Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired transcription in Alzheimer's disease: key role in mitochondrial dysfunction and oxidative stress.
    Caldeira GL; Ferreira IL; Rego AC
    J Alzheimers Dis; 2013; 34(1):115-31. PubMed ID: 23364141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondria in aging and Alzheimer's disease.
    Crouch PJ; Cimdins K; Duce JA; Bush AI; Trounce IA
    Rejuvenation Res; 2007 Sep; 10(3):349-57. PubMed ID: 17708691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction: cause and consequence of Alzheimer's disease.
    Friedland-Leuner K; Stockburger C; Denzer I; Eckert GP; Müller WE
    Prog Mol Biol Transl Sci; 2014; 127():183-210. PubMed ID: 25149218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Related Disorders: From Molecular Mechanisms to Clinical Evidence.
    Lejri I; Agapouda A; Grimm A; Eckert A
    Oxid Med Cell Longev; 2019; 2019():9695412. PubMed ID: 31214285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
    Cheng XR; Zhou WX; Zhang YX
    Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial effects of Ginkgo biloba extract.
    Eckert A
    Int Psychogeriatr; 2012 Aug; 24 Suppl 1():S18-20. PubMed ID: 22784423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early molecular changes in Alzheimer disease: can we catch the disease in its presymptomatic phase?
    Wirz KT; Keitel S; Swaab DF; Verhaagen J; Bossers K
    J Alzheimers Dis; 2014; 38(4):719-40. PubMed ID: 24072070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.